AHealthyMe
-
Login Registration Sample personal Change Profile Log Out
Search AHealthyMe!  
Personalize AHealthyMe! -Sign up for our Newsletter!

Women's HealthMen's HealthHelath After 60Children's HealthPregnancyFitness & NutritionAlternative HealthLifestyle & WellnessWork & HealthIlls & ConditionsDental HealthSelf-Care CentersMedical LibraryCool ToolsMultimediaEn Español-

Blue Cross Blue Shield of Massachusetts

You are here: Home > Health A to Z > Hypercoagulable states



Hypercoagulable states

Definition
Causes, incidence, and risk factors
Alternative Names


 Definition  

Hypercoagulable states are conditions that may lead to the abnormal development of blood clots. Blood clots can develop in either arteries or veins.

See also:

  • Blood clots in the legs
  • Deep venous thrombosis (DVT)
  • Hepatic vein obstruction (Budd-Chiari syndrome)
  • Mesenteric vein thrombosis
  • Pulmonary embolus
  • Stroke
  • Stroke secondary to cardiogenic embolism

 Alternative Names  

Thromboembolic states

 Causes, incidence, and risk factors  

Conditions that can lead to the formation of blood clots include prolonged bedrest, dehydration, poor positioning (such as crossing the legs), sitting for long periods (such as in a plane or car), and prolonged use of an intravenous catheter.

Some medical situations can lead to the formation of abnormal blood clots. These include cancer, recent surgery or trauma, obesity, liver or kidney disease, and some medications.

In women, birth control pills or hormone replacement therapy increase the risk of blood clots, and the risk is greatly increased in those who also smoke. The periods before, during, and after pregnancy also increase the risk of clots.

A tendency to form abnormal blood clots also can be related to genetic problems. For example, two relatively common inherited conditions that affect clotting are Factor V Leiden and the Prothrombin mutation 20210A. Rare inherited conditions include Protein C, Protein S, and Anti-thrombin III deficiencies.

Review date: 5/3/2006

Reviewed By: William Matsui, MD, Assistant Professor of Oncology, Division of Hematologic Malignancies, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.